Joe Aoun(@Joe_Aoun_) 's Twitter Profileg
Joe Aoun

@Joe_Aoun_

IC/SHD Fellow at Houston Methodist DeBakey Heart&Vascular Center, Chair FIT Texas ACC, former Chief Cardiology Fellow

ID:475759677

calendar_today27-01-2012 12:08:32

518 Tweets

1,1K Followers

921 Following

Texas Chapter - ACC(@txchapteracc) 's Twitter Profile Photo

Your TCACC President Shelley Hall reflects on some of the accomplishments of the TCACC over the last year and what we have to look forward to. 👏We hope you’ll be a part of our progress in 2024 and for years to come!

account_circle
Samarth Thakkar(@thakkar_samarth) 's Twitter Profile Photo

It was an honor to present a case complication at Cardiovascular Research Foundation followed by thought-provoking discussions and invaluable insights from leaders in the field. Truly a learning experience!! Special thanks to Neal Kleiman Hassaan B Arshad Joe Aoun

It was an honor to present a case complication at #FELLOWS2024 @crfheart followed by thought-provoking discussions and invaluable insights from leaders in the field. Truly a learning experience!! Special thanks to @n_kleiman @HassaanBArshad1 @Joe_Aoun_
account_circle
Saliha Erdem MD(@mderdem3) 's Twitter Profile Photo

-TEER offers an alternative treatment for transfusion dependent anemia post surgical mitral valve repair among pts who are at high risk for redo surgery American College of Cardiology .24

#M-TEER offers an alternative treatment for transfusion dependent #hemolytic anemia post surgical mitral valve repair among pts who are at high risk for redo surgery @ACCinTouch #ACC.24
account_circle
Joe Aoun(@Joe_Aoun_) 's Twitter Profile Photo

Strong work Isadora Mathias, MD , nice case showing how FMR is very dependent on loading conditions, even within “normal blood pressure range”. After max GDMT, M-TEER can help our patients! Houston Methodist Cardiovascular Fellowships Houston Methodist CV

account_circle
Nadeen N. Faza, M.D.(@NadeenFaza) 's Twitter Profile Photo

👏2024 is the year to treat terrible TR !
& T- have been approved, with studies demonstrating improvement in in high-risk patients with a very debilitating disease! Patient selection is🔑

👏2024 is the year to treat terrible TR #TreatTR! #EVOQUE #TTVR & #TriClip T-#TEER have been #FDA approved, with studies demonstrating improvement in #QoL in high-risk patients with a very debilitating disease! Patient selection is🔑 #Cardiotwitter #CardioX #iecho #echofirst
account_circle